McKesson CorporationMCK
Close of Friday, October 23, 2026 · McKesson Corporation is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$1,001
vs its Pivot
+16.6%
OnlyAlpha Score
76
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +15.1% | +22.4% | +26.3% | +30.6% | +38.1% |
Dividend: $3.40 a share over the last 12 months, a 0.34% yield at today's price.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| Tudor Investment Paul Tudor Jones | 0.4% of holdings |
| Renaissance Technologies founded by Jim Simons | 0.4% of holdings |
| Lone Pine Capital founded by Stephen Mandel | 0.3% of holdings |
| Bridgewater Associates founded by Ray Dalio | 0.2% of holdings |
Members of Congress who traded it
| Ro Khanna D · CA | 14 buys · 10 sells · last buy 2026-08-10 |
| Josh Gottheimer D · NJ | 3 buys · 11 sells · last sell 2025-04-09 |
| Lois Frankel D · FL | 7 buys · 3 sells · last buy 2022-03-08 |
| Gil Cisneros D · CA | 3 buys · 3 sells · last sell 2025-12-19 |
| Jonathan Jackson D · IL | 4 buys · 2 sells · last sell 2026-06-15 |
| Sheldon Whitehouse D · RI | 4 buys · 1 sells · last sell 2017-09-20 |
| Jared Moskowitz D · FL | 5 buys · 0 sells · last buy 2025-12-02 |
| Earl Blumenauer D · OR | 3 buys · 2 sells · last sell 2024-04-04 |
Suppliers, customers and partners
Sells to MCK
| Eli Lilly | significant % of revenue each (XBRL: 16-24% each) |
| AbbVie | substantially all US sales combined; none >43% |
| Amgen | >10% of revenue each; 77% of gross rev combined |
| Gilead Sciences | ~90% of US gross sales combined |
| Embecta | three largest distributors; ~42% of gross sales combined |
| Amphastar Pharmaceuticals | 24% of net revenues |
| Amneal Pharmaceuticals | top-4 customers; ~71% of net revenue combined |
MCK sells to
| CVS Health | ~24% of revenue |
Partners and deals
| Walmart | ClarusONE generic sourcing |
From the companies' own annual reports filed with the SEC.
Healthcare · Drug distributors and pharmacies
Get MCK in your free daily emailAfter every close: whether MCK is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track MCK free → Full Stock check
Track MCK free → Full Stock check